Filing Details

Accession Number:
0000899243-22-038384
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-13 20:24:08
Reporting Period:
2022-12-09
Accepted Time:
2022-12-13 20:24:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1750019 Tcr2 Therapeutics Inc. TCRR Biological Products, (No Disgnostic Substances) (2836) 474152751
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1875057 Peter Olagunju C/O Tcr2 Therapeutics
100 Binney Street
Cambridge MA 02142
Chief Technical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-12-09 1,561 $1.13 27,361 No 4 S Direct
Common Stock Disposition 2022-12-12 1,610 $1.10 25,751 No 4 S Direct
Common Stock Disposition 2022-12-13 1,659 $1.07 24,092 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 28,922 Direct
Footnotes
  1. The sales reported represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.